By using CBA/J mice as responders and a murine fibroblast-like cell line spontaneously transformed in vitro (Swiss-12) as the material to be implanted, the development of tumours and the natural killer (NK) cell activity levels in the spleen were tested, respectively, in relation to the in vivo administration of several immunomodulators; i.e., beta-interferon (β-IF), macrophage-dervied interleukin-1 (IL-1), or indomethacin (IND), as a prostaglandin inhibitor. For each immunomodulating agent, two separate schemes of administration were used as follows: for 14 days, on alternate days, preceding the tumour cell implantation, or for 14 days, on alternate days, after tumour cell implantation. In both schemes, β-IF was able to reduce the tumour size as well as to stimulate the NK cell cytotoxicity. On the other hand, only pre-treatment with IL-1 and only post-treatment with IND exhibited such an effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.